Updated results of a phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.

被引：1
|
作者：
Han, Boram
Kim, Hyeong Su
Choi, Dae Ro
Shim, Byoung Yong
Lee, Kyung Hee
Kim, Jin Won
Kim, Jung Han
Kim, Jung Hoon
Kim, Ho Young
Song, Hunho
Park, Choong Kee
Moon, Sung Hoon
Kim, Jong Hyeok
Jeon, Jang Yong
Lee, Jung Woo
Zang, Dae Young
机构：
[1] Hallym Univ, Med Ctr, Anyang, South Korea
[2] Hallym Univ, Med Ctr, Coll Med, Seoul, South Korea
[3] Hallym Univ, Chuncheon Sacred Heart Hosp, Chunchon, South Korea
[4] Cathol Univ Kore, St Vincents Hosp, Seoul, South Korea
[5] Yeungnam Univ Hosp, Dept Hemato Oncol, Daegu, South Korea
[6] Seoul Natl Univ Bundang Hosp, Dept Internal Med, Seoul, South Korea
[7] Hallym Univ, Coll Med, Med Ctr, Dept Internal Med, Anyang, South Korea
[8] Hallym Univ, Chuncheon Sacred Heart Hosp, Div Hematol Oncol, Dept Internal Med, Chunchon, South Korea
[9] Hallym Univ, Kang Dong Sacred Heart Hosp, Med Ctr, Seoul, South Korea
[10] Hallym Univ, Med Ctr, Anyang, South Korea
[11] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15778
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15778
引用
下载
收藏
页数：6
相关论文
共 50 条
  • [31] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [32] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Do-Youn Oh
    Yongjun Cha
    In-Sil Choi
    So-Young Yoon
    In Keun Choi
    Jee Hyun Kim
    Sang Cheul Oh
    Chang Duck Kim
    Jae Sun Kim
    Yung-Jue Bang
    Yeul Hong Kim
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 527 - 536
  • [33] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Oh, Do-Youn
    Cha, Yongjun
    Choi, In-Sil
    Yoon, So-Young
    Choi, In Keun
    Kim, Jee Hyun
    Oh, Sang Cheul
    Kim, Chang Duck
    Kim, Jae Sun
    Bang, Yung-Jue
    Kim, Yeul Hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 527 - 536
  • [34] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
    Morizane, Chigusa
    Okusaka, Takuji
    Furuse, Junji
    Ishii, Hiroshi
    Ueno, Hideki
    Ikeda, Masafumi
    Nakachi, Kohei
    Najima, Mina
    Ogura, Takashi
    Suzuki, Eiichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 313 - 319
  • [35] Prognostic index based on the phase III study of gemcitabine plus S-1, S-1 alone or gemcitabine alone in patients with advanced pancreatic cancer (GEST study)
    Ueno, H.
    Nagase, M.
    Hamamoto, Y.
    Egawa, S.
    Ohkawa, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S462 - S462
  • [36] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
    Chigusa Morizane
    Takuji Okusaka
    Junji Furuse
    Hiroshi Ishii
    Hideki Ueno
    Masafumi Ikeda
    Kohei Nakachi
    Mina Najima
    Takashi Ogura
    Eiichiro Suzuki
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 313 - 319
  • [37] Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
    Sudo, Kentaro
    Hara, Ryusuke
    Nakamura, Kazuyoshi
    Kita, Emiri
    Tsujimoto, Akiko
    Yamaguchi, Taketo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 195 - 202
  • [38] Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
    Kentaro Sudo
    Ryusuke Hara
    Kazuyoshi Nakamura
    Emiri Kita
    Akiko Tsujimoto
    Taketo Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 195 - 202
  • [39] Phase II study of gemcitabine in patients with advanced pancreatic cancer
    Carmichael, J
    Fink, U
    Russell, RCG
    Spittle, MF
    Harris, AL
    Spiessi, G
    Blatter, J
    BRITISH JOURNAL OF CANCER, 1996, 73 (01) : 101 - 105
  • [40] PHASE II STUDY OF GEMCITABINE/S-1 COMBINATION THERAPY IN PATIENTS WITH ADVANCED BILIARY TRACT CANCER
    Kanai, Masashi
    Hatano, Etsuro
    Tsumura, Takehiko
    Asada, Masanori
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Hamada, Akihiko
    Inoue, Naoya
    Mori, Yukiko
    Yoshimura, Kenichi
    Tada, Shinsuke
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Osaki, Yukio
    Chiba, Tsutomu
    ANNALS OF ONCOLOGY, 2010, 21 : 19 - 19
12345